BioQuest Corp.

BQST

US09076H1023

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 12:27:12 08/05/2024 am IST			5-day change	1st Jan Change
0.0227 ^USD	-82.54%		-.--%	-98.83%

2022	BioQuest Corp. cancelled the acquisition of 49% stake in Progressus Clean Technologies Inc. from Powertap Hydrogen Capital Corp. (OTCPK:MOTN.F), T2M Global and Aberdeen International Inc..	CI
2022	BioQuest Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	CI

BioQuest Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021

May 16, 2022 at 03:47 pm IST

BioQuest Corp. reported earnings results for the second quarter and six months ended October 31, 2021. For the second quarter, the company reported net loss was USD 0.187939 million compared to USD 0.630281 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.
For the six months, net loss was USD 0.624984 million compared to USD 0.952511 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.12 a year ago.

Latest news about BioQuest Corp.

BioQuest Corp. cancelled the acquisition of 49% stake in Progressus Clean Technologies Inc. from Powertap Hydrogen Capital Corp. (OTCPK:MOTN.F), T2M Global and Aberdeen International Inc..	22/22/22	CI
BioQuest Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	12/22/12	CI
BioQuest Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	15/22/15	CI
BioQuest Corp. Auditor Raises 'Going Concern' Doubt	15/22/15	CI
BioQuest Corp. entered into a letter of intent to acquire 49% stake in Progressus Clean Technologies Inc. from Powertap Hydrogen Capital Corp. (OTCPK:MOTN.F), T2M Global and Aberdeen International Inc..	23/22/23	CI
BioQuest Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	27/22/27	CI
BioQuest Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	16/22/16	CI
BioQuest Corp. Reports Earnings Results for the First Quarter Ended July 31, 2021	30/22/30	CI
Bioquest Corp. Reports Earnings Results for the Full Year Ended April 30, 2021	14/21/14	CI
Bioquest Corp. Reports Earnings Results for the Third Quarter Ended January 31, 2021	16/21/16	CI
Bioquest Corp. Reports Earnings Results for the Second Quarter Ended October 31, 2020	15/20/15	CI
BioQuest Corp. Reports Earnings Results for the First Quarter Ended July 31, 2020	15/20/15	CI
BioQuest Corp. Announces a New Woman’s Skin Care line, Vital-Q	02/20/02	CI
BioQuest Corp. Appoints Thomas Hemingway as Chairman and CEO	18/19/18	CI
Pillar Marketing Group, Inc. acquired 60% interest in Select-TV Solutions, Inc from Algonquin Partners Inc for $0.14 million.	18/19/18	CI
Select-TV-Solutions, Inc. will Change its Name to BioQuest Corp	15/19/15	CI
Cannonco PLC cancelled the acquisition of Select-TV Solutions, Inc..	22/16/22	CI
Select-TV Solutions, Inc. Appoints Brooks Pickering as President and COO	12/15/12	CI
Cannonco PLC signed a memorandum of understanding to acquire Select-TV Solutions, Inc..	22/15/22	CI
Select-TV Solutions, Inc. announced that it expects to receive $2.5 million in funding.	10/14/10	CI
Select-TV Solutions, Inc. acquired Select-TV Solutions, Inc.	06/14/06	CI
Select-TV Solutions, Inc. Appoints Geoffrey Mott as Chief Executive Officer	09/14/09	CI
Sedition Films, Inc. has Changed its Name to Select-TV Solutions, Inc	25/14/25	CI
Sedition Films, Inc. Announces Appointment of Philippe Germain as Chairman of the Board of Directors	15/14/15	CI
Sedition Films, Inc. Announces Directorate Changes	11/14/11	CI

Chart BioQuest Corp.

Duration

Period

More charts

Company Profile

Bioquest Corp. is primarily focused on acquiring companies in the green energy sector. The Company has executed a letter of intent to acquire all of the issued and outstanding shares of Progressus Clean Technologies, Inc. (Progressus), which is a private company. Progressus is a venture stage green technology company focused on the development of hydrogen generation and separation technologies. Progressus owns the rights to intellectual property that enables the extraction of dilute amounts of hydrogen at purity from a various gas stream. The Company has not generated any revenue.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BIOQUEST CORP.	-98.83%	3L
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.78%	4.33TCr
OTSUKA HOLDINGS CO., LTD.	+27.64%	2.24TCr
SANDOZ GROUP AG	+19.66%	1.55TCr
CIPLA LIMITED	+18.68%	1.45TCr
ZYDUS LIFESCIENCES LIMITED	+54.64%	1.29TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-11.39%	655.78Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+17.73%	587.1Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr